MedPath

Samarium Sm-153

Generic Name
Samarium Sm-153
Drug Type
Small Molecule
Chemical Formula
Sm
CAS Number
15766-00-4
Unique Ingredient Identifier
6Q1KA41UWM

Overview

Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer.

Background

Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer.

Indication

No indication information available.

Associated Conditions

  • Skeletal pain

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath